全球羊膜市场规模、份额、成长分析、副产品（冷冻保存和脱水）、按应用（手术伤口、眼科）- 2024-2031 年产业预测

Global Amniotic Membrane Market Size, Share, Growth Analysis, By Product(Cryopreserved, and Dehydrated), By Application(Surgical Wounds, Ophthalmology) - Industry Forecast 2024-2031

出版日期: 2024年03月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球羊膜市场规模为34.2亿美元，预计将从2023年的39亿美元成长到2031年的111.2亿美元，在预测期（2024-2031年）复合年增长率为14%。

为眼科问题、伤口癒合和组织再生提供有效的治疗是羊膜市场的目标。羊膜可以製成用于治疗糖尿病足溃疡和腿部静脉溃疡等长期伤口的生物支架或敷料。这个市场主要是由眼部疾病和慢性伤口发生率上升所推动的。由于糖尿病和老年黄斑部病变等疾病的盛行率不断上升，对复杂伤口护理和眼部治疗的需求显着增加。羊膜市场正在成长，但存在一些限制因素。在某些领域，由于伦理和监管限制，使用人类组织存在困难。市场也存在品质控制和产品一致性的问题。羊膜的治疗功效取决于其在整个生产和分销过程中保持的完整性和活力。全球羊膜市场的目标是为眼部治疗和伤口癒合提供有效的解决方案。眼部疾病和慢性伤口发生率的不断上升正在推动市场的发展。然而，复杂的法规、昂贵的费用以及品质控制的困难等限制因素。然而，技术的发展和对再生医学的日益关注带来了市场成长的前景。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

MiMedx Group, Inc. (US)
TissueTech, Inc. (US)
Skye Biologics, Inc. (US)
Alliqua BioMedical, Inc. (US)
Amnio Technology, LLC (US)
Katena Products, Inc. (US)
Applied Biologics LLC (US)
Amniox Medical, Inc. (US)
Derma Sciences, Inc. (US)
Organogenesis Holdings Inc. (US)
Smith & Nephew plc (UK)
Integra LifeSciences Corporation (US)
Osiris Therapeutics, Inc. (US)
AmnioLife Corporation (US)
Human Regenerative Technologies, LLC (US)
AlloSource (US)
LifeCell International Pvt. Ltd. (India)
Amnion Life (US)
Surgenex (US)
NuVision Biotherapies Ltd. (UK)

简介目录

Product Code: SQMIG35H2086

Global Amniotic Membrane Market size was valued at USD 3.42 billion in 2022 and is poised to grow from USD 3.90 billion in 2023 to USD 11.12 billion by 2031, growing at a CAGR of 14% during the forecast period (2024-2031).

Providing efficient treatments for ophthalmic problems, wound healing, and tissue regeneration is the aim of the amniotic membrane market. A biological scaffold or dressing for long-term wounds, like diabetic foot ulcers and venous leg ulcers, can be made from the amniotic membrane. The market is primarily driven by the rising incidence of eye illnesses and chronic wounds. The need for sophisticated wound care and ocular treatments has increased significantly due to the rising prevalence of diseases including diabetes and age-related macular degeneration. The market for amniotic membranes is growing, however there are several obstacles that are limiting it. In certain areas, using tissues originating from humans presents difficulties due to ethical and regulatory constraints. The market also has issues with quality control and product uniformity. The therapeutic efficacy of amniotic membranes depends on their integrity and vitality being maintained throughout the production and distribution procedures. The goal of the worldwide amniotic membrane market is to supply efficient solutions for eye therapy and wound healing. The growing incidence of eye illnesses and chronic wounds is driving the market. Restraints, however, come from complicated regulations, expensive expenses, and difficulties with quality control. However, technological developments and an increasing focus on regenerative medicine present prospects for market increase.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Amniotic Membrane Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Amniotic Membrane Market Segmental Analysis

The product, application, and geographic segments of the worldwide amniotic membrane market are divided up. The market is divided into dehydrated and cryopreserved segments based on the product. The market is divided into surgical wounds, ophthalmology, and other segments based on application. The market is divided into Latin America, Middle East and Africa, Asia Pacific, North America, and Europe.

Drivers of the Global Amniotic Membrane Market

One major factor driving the amniotic membrane market is the rising prevalence of chronic wounds, such as diabetic foot ulcers and venous leg ulcers. Amniotic membranes have demonstrated encouraging outcomes in aiding healing and tissue regeneration, which is why these conditions demand efficient wound healing therapies.

Restraints in the Global Amniotic Membrane Market

In certain areas, the use of tissues derived from humans, such amniotic membranes, presents ethical and regulatory challenges. Tight laws governing the acquisition, processing, and safety of tissue might present problems for industry participants, restricting their capacity to supply goods in specific areas.

Market Trends of the Global Amniotic Membrane Market

Originally, amniotic membranes were applied to wound healing. But there's a rising movement to investigate their possibilities in other therapeutic domains, such orthopedics, dentistry, and ophthalmology. Amniotic membrane-based medicines are becoming more widely used, and researchers and businesses are looking into additional indications.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Amniotic Membrane Market by Product

Market Overview
Cryopreserved
and Dehydrated

Global Amniotic Membrane Market by Application

Market Overview
Surgical Wounds
Ophthalmology
and Others

Global Amniotic Membrane Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

MiMedx Group, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TissueTech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Skye Biologics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alliqua BioMedical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amnio Technology, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Katena Products, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Biologics LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amniox Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Derma Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organogenesis Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osiris Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AmnioLife Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Human Regenerative Technologies, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AlloSource (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeCell International Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amnion Life (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Surgenex (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuVision Biotherapies Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments